Relapsed or Refractory Acute Myeloid Leukemia: Venetoclax and Alvocidib
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Relapsed Or Refractory Acute Myeloid Leukemia
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Other Inclusion Criteria:
1. Diagnosis of Relapsed or Refractory Acute Myeloid Leukemia
You may not be eligible for this study if the following are true:
-
1. No known central nervous system leukemia. 2. No severe chronic obstructive pulmonary disease (COPD) with hypoxemia. 3. No history of previous enrollment in Studies NCT02993523 or NCT03069352. 4. No history of exposure to alvocidib or any other CDK9 inhibitor.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.